Digging Into Boutique Bank Earnings

11:28am, Friday, 26'th Jul 2024
Evercore Inc. reported record revenue as dealmaking led to a surge in advisory fees. Matthew Monks takes a deep dive into the sector on "Wall Street Beat" on "Bloomberg Open Interest.

4 Stocks That Recently Hiked Dividends in Focus

10:35am, Thursday, 25'th Jul 2024
Cintas Corporation (CTAS), Citigroup Inc. (C), Community Financial System, Inc. (CBU) and Bank First Corporation (BFC) recently hiked their dividends.
Citigroup (C) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
With mixed second-quarter bank earnings under our belt, there is a better sense of how capital markets may unfold over the second half of the year. Messages were somewhat mixed, but there is an underl

3 Bank Stocks Pulling Back from 2-Year Highs

01:38pm, Monday, 22'nd Jul 2024
Bank stocks just kicked off another earnings season , making way for giants in other industries to announce their  quarterly results.
24/7 Insights With the Democrat Convention right around the corner, the field for November is almost set.
Citigroup beats Q2 estimates with revenue and earnings exceeding analyst expectations, driven by strong performance in Markets and Investment Banking. Despite concerns about higher costs for FY 2024,
A former Citigroup managing director who said she was fired because she refused to mislead a federal regulator about the bank's risk management accused Citigroup's chief operating officer of intention
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
JPM is “winning” for its shareholders, while Jane Fraser continues to turn around Citigroup. Coming into last Friday morning's call, our revenue estimate for JPM was $42 billion and change, but th
Dividend stocks are a powerful multiplier. Not only do investors benefit from capital appreciation from the stock but their portfolios are supercharged by the dividend payments increasing total return
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today
Citigroup's Q2 results were better than expected on a core basis, with a $0.13/beat at the core pre-provision profit line on stronger than expected capital markets and commercial banking. The Services
Bond yields for three of the four biggest money-center banks have continued to tighten against Treasurys following their earnings updates, in a positive sign of demand ahead of billions of dollars in
It's no secret that most of the market's attention has been centered around the technology sector, especially in stocks dealing with the advancement and global adoption of artificial intelligence, nam
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE